LODAPOLIMAB

UNII: NR4MAD6PPB
Preferred Substance Name: LODAPOLIMAB

2118349-31-6
IMMUNOGLOBULIN G1 (240-ALANINE, 241-GLUTAMIC ACID, 243-ALANINE, 336-SERINE, 337-SERINE), ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL LY3300054 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3300054 .LAMBDA.-CHAIN, DIMER
LODAPOLIMAB [INN]
LODAPOLIMAB [USAN]
LODAPOLIMAB [WHO-DD]
LY3300054
LY-3300054
LY3300054, A FULLY HUMAN IGG1.LAMBDA. ANTI-PD-L1 MONOCLONAL ANTIBODY

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

LODAPOLIMAB

Synonyms and Mappings

Resources

Note